Predictive value of cell-surface markers in infections in critically ill patients: Protocol for an observational study (ImmuNe FailurE in Critical Therapy (INFECT) Study)

BMJ Open

Volumn 6, Issue 7, 2016, Pages

  Conway Morris, Andrew ^a,b   Datta, Deepankar ^b   Shankar Hari, Manu ^c   Weir, Christopher J ^b   Rennie, Jillian ^b   Antonelli, Jean ^d   Rossi, Adriano G ^b   Warner, Noel ^e   Keenan, Jim ^e   Wang, Alice ^e   Brown, K Alun ^f   Lewis, Sion ^f   Mare, Tracey ^f   Simpson, A John ^g   Hulme, Gillian ^g   Dimmick, Ian ^g   Walsh, Timothy S ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e BD Technologies   (United States)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Immunology; Infectious Diseases

Indexed keywords

CELL SURFACE MARKER; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C5A RECEPTOR; HLA DR ANTIGEN; MEMBRANE PROTEIN;

ADULT; ARTICLE; COHORT ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE PREDISPOSITION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; ADOLESCENT; ARTIFICIAL VENTILATION; CROSS INFECTION; CYTOLOGY; FEMALE; IMMUNE SYSTEM; IMMUNOLOGY; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; METABOLISM; METHODOLOGY; MONOCYTE; MORTALITY; NEUTROPHIL; REGULATORY T LYMPHOCYTE; RISK FACTOR;

ADOLESCENT; BIOMARKERS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNE SYSTEM; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MEMBRANE PROTEINS; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTOR, ANAPHYLATOXIN C5A; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; RISK FACTORS; T-LYMPHOCYTES, REGULATORY;

EID: 84979599328     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011326     Document Type: Article

References (18)

1. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274:639-44.
3. Mendes ET, Dulley F, Basso M, et al. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. Int J Infect Dis 2012;16:e424-8.
4. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008;300:413-21.
5. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013;13:862-74.
6. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011;208:2581-90.
7. Adib-conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 2007;581:3723-33.
8. Sakamoto Y, Mashiko K, Matsumoto H, et al. Systemic inflammatory response syndrome score at admission predicts injury severity, organ damage and serum neutrophil elastase production in trauma patients. J Nihon Med Sch 2010;77:138-44.
9. Muller Kobold AC, Tulleken JE, Zijlstra JG, et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000;26:883-92.
10. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;21:2594-605.
11. Conway Morris A, Kefala K, Wilkinson TS, et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med 2009;180:19-28.
12. Döcke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997;3:678-81.
13. Venet F, Chung CS, Monneret G, et al. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 2008;83:523-35.
14. Conway Morris A, Anderson N, Brittan M, et al. Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients. Br J Anaesth 2013;111:778-87.
15. Venet F, Chung CS, Kherouf H, et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009;35:678-86.
16. Lukaszewicz AC, Grienay M, Resche-Rigon M, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 2009;37:2746-52.
17. Meisel C, Schefold JC, Pschowski R, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009;180:640-8.
18. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527.